AbbVie's earnings and sales beat are likely to positively impact investor sentiment in the short term. The beat on both top and bottom lines indicates operational efficiency and market strength, despite the year-over-year decrease in EPS. This mixed result, with a beat on expectations but a slight decrease in EPS compared to the previous year, suggests a cautiously optimistic outlook for the stock. The increase in sales, albeit modest, further supports the potential for a positive short-term price movement.